Clinical trial
Plasma P-tau2017 and Quantitative Amyloid PET Imaging in a Cognitively Normal Population
NCT05164536 is registered in ClinicalTrials.gov with Invicro as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Plasma P-tau2017 and Quantitative Amyloid PET Imaging in a Cognitively Normal Population
- Lead sponsor
- Invicro
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- August 27, 2021
- Completion date
- November 8, 2022
- Enrollment
- 140 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.